Zhong Yichen, Wilkinson-White Lorna, Zhang Esther, Mohanty Biswaranjan, Zhang Belinda B, McRae Madeline S, Luo Rachel, Allport Thomas A, Duff Anthony P, Zhao Jennifer, El-Kamand Serene, Du Plessis Mar-Dean, Cubeddu Liza, Gamsjaeger Roland, Ataide Sandro F, Kwan Ann H
Currently or formerly at School of Life and Environmental Sciences, The University of Sydney, Sydney, NSW, Australia.
Sydney Analytical Core Research Facility, The University of Sydney, Sydney, NSW, Australia.
PLoS One. 2024 Sep 16;19(9):e0310565. doi: 10.1371/journal.pone.0310565. eCollection 2024.
RNA-binding proteins (RBPs) are a major class of proteins that interact with RNAs to change their fate or function. RBPs and the ribonucleoprotein complexes they constitute are involved in many essential cellular processes. In many cases, the molecular details of RBP:RNA interactions differ between viruses, prokaryotes and eukaryotes, making prokaryotic and viral RBPs good potential drug targets. However, targeting RBPs with small molecules has so far been met with limited success as RNA-binding sites tend to be extended, shallow and dynamic with a mixture of charged, polar and hydrophobic interactions. Here, we show that peptide nucleic acids (PNAs) with nucleic acid-like binding properties and a highly stable peptide-like backbone can be used to target some RBPs. We have designed PNAs to mimic the short RNA stem-loop sequence required for the initiation of prokaryotic signal recognition particle (SRP) assembly, a target for antibiotics development. Using a range of biophysical and biochemical assays, the designed PNAs were demonstrated to fold into a hairpin structure, bind the targeted protein and compete with the native RNA hairpin to inhibit SRP formation. To show the applicability of PNAs against other RBPs, a PNA was also shown to bind Nsp9 from SARS-CoV-2, a protein that exhibits non-sequence-specific RNA binding but preferentially binds hairpin structures. Taken together, our results support that PNAs can be a promising class of compounds for targeting RNA-binding activities in RBPs.
RNA结合蛋白(RBPs)是一类主要的蛋白质,它们与RNA相互作用以改变其命运或功能。RBPs及其构成的核糖核蛋白复合物参与许多重要的细胞过程。在许多情况下,病毒、原核生物和真核生物中RBP与RNA相互作用的分子细节有所不同,这使得原核生物和病毒的RBPs成为潜在的良好药物靶点。然而,由于RNA结合位点往往具有延伸、浅且动态的特点,同时存在带电、极性和疏水相互作用的混合,用小分子靶向RBPs到目前为止取得的成功有限。在这里,我们表明具有类似核酸结合特性和高度稳定的类肽主链的肽核酸(PNA)可用于靶向某些RBPs。我们设计了PNA来模拟原核生物信号识别颗粒(SRP)组装起始所需的短RNA茎环序列,SRP是抗生素开发的一个靶点。通过一系列生物物理和生化分析,证明设计的PNA折叠成发夹结构,与靶向蛋白结合,并与天然RNA发夹竞争以抑制SRP形成。为了展示PNA对其他RBPs的适用性,还证明了一种PNA能结合严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的Nsp9蛋白,该蛋白表现出非序列特异性的RNA结合,但优先结合发夹结构。综上所述,我们的结果支持PNA可能是一类有前景的化合物,可用于靶向RBPs中的RNA结合活性。